Precipitated Withdrawal

What precipitated withdrawal is

Heroin, morphine, methadone and fentanyl fully switch on the brain's opioid receptors, and regular use makes the body depend on that signal. Buprenorphine switches the receptors on only partly but holds them more tightly, so it can push a full opioid off and leave a sudden gap.^3,9 Naltrexone, naloxone and nalmefene block the receptors with no opioid effect at all.^1,5,6

Ordinary withdrawal, after stopping opioids, is uncomfortable but not generally thought to need a hospital. When an opioid blocker sets it off all at once, the tablet and Vivitrol labels warn it can be severe enough to require one.^1,4

Clinicians score withdrawal on the 11-item Clinical Opiate Withdrawal Scale (COWS).¹⁰ In a lab study, 106 people on daily morphine were given naloxone. About 90% hit their worst symptoms within 60 minutes, and a rise of 6 COWS points, or 10 points on the patients' own withdrawal scale, was the change they felt as meaningful.¹¹ For buprenorphine, the American Society of Addiction Medicine (ASAM) uses a COWS rise of more than 5 points soon after the first dose.¹² Definitions vary between studies.⁷

Three ways it happens

Symptoms, and when it becomes an emergency

The nalmefene labels list body aches, diarrhea, a fast heartbeat, fever, a runny nose, goose bumps, sweating, yawning, nausea or vomiting, restlessness, shivering, stomach cramps and higher blood pressure.^6,14 In the naloxone lab study, teary eyes, a runny nose, yawning, sweating, hot flashes and changes in pupil size stood out as signs of withdrawal set off by a blocker.¹¹

With naltrexone tablets, confusion, sleepiness and visual hallucinations have occurred, and fluid lost to vomiting and diarrhea has needed IV fluids. Reports collected after approval include cases "severe enough to require hospital admission, and in some cases, management in the intensive care unit."¹ Two case reports after Vivitrol shots describe a woman with a blood pressure emergency treated in intensive care and a man so agitated and confused that he needed a breathing tube.¹⁵ Some people may become aggressive when an overdose is reversed suddenly.⁶

How long it lasts depends on the drug

• Naloxone (Narcan). Symptoms can start within minutes and fade in about 2 hours; the dose and the type of opioid dependence change both.⁵ It can wear off before the opioid does, so stay with the person until help arrives.^5,16

• Nalmefene (Opvee, Zurnai). It acts longer than naloxone; the nasal spray's half-life is 11.4 hours.⁶ A review of case reports on long-acting blockers, 4 of them involving nalmefene, found that symptoms took 3 to 48 hours to settle with treatment.¹³

• Naltrexone tablets. Withdrawal has usually begun within 5 minutes of a tablet and lasted up to 48 hours.¹

• Vivitrol. The shot lasts about a month and can't be taken back out.⁴ Only 2 of the 27 papers in the case-report review involved the shot.¹³

• Buprenorphine. In the 1,200-patient emergency study below, 8 of the 9 people who had it went home after 2 hours 50 minutes to 22 hours 39 minutes in the emergency department; 1 left against medical advice.² People switching from methadone or other long-acting opioids are more prone to withdrawal that is worse and lasts longer.⁹

How often it happens with Suboxone, and where fentanyl fits

The review's authors called the risk low and no reason to avoid buprenorphine.⁷ In the survey, taking buprenorphine within 24 hours of fentanyl raised the odds of severe withdrawal about fivefold (odds ratio 5.2), and within 24 to 48 hours about threefold (3.35).¹⁸

Fentanyl comes off the receptor slowly and builds up in body fat with long-term use, a suspected reason for the extra risk.² In the hospital study, a body mass index of 30 or more (adjusted odds ratio 5.12) and a urine fentanyl level of 200 ng/mL or more (8.37) were tied to higher odds; both estimates had wide confidence intervals.¹⁷

With naltrexone or Vivitrol, more opioids make it dangerous

Don't take more opioids to push through a naltrexone or nalmefene block. The block can be overcome, and the labels warn that trying "may lead to life-threatening opioid intoxication or fatal overdose."^1,4,6 Get emergency care instead.

The labels tell clinicians to be ready to treat this withdrawal with non-opioid medicines.⁴ In the case-report review, emergency teams most often used IV fluids, anti-nausea medicines, benzodiazepines and clonidine. Buprenorphine shortened or eased withdrawal in several cases and is being explored as a treatment. There is no evidence-based guideline yet.¹³

If you take naltrexone for alcohol, tell your prescriber about any opioids

The labels record cases in people treated for alcohol dependence whose prescriber didn't know they also used opioids or depended on them.^1,4 Before the first dose, you need to be off all opioids, including tramadol, street drugs, prescription pain pills, cough, cold or diarrhea medicines with opioids, and buprenorphine or methadone.⁴ Hidden sources are listed under cough syrups, diarrhea pills and kratom.

How clinicians lower the risk, and what they do if it happens

Starting buprenorphine. The Suboxone label puts the first dose at the point when objective signs of moderate withdrawal appear, at least 6 hours after the last opioid.⁹ SAMHSA's guide for clinicians says the risk rises with heavier dependence, a shorter gap since the last full opioid and a bigger first dose.³

For people using fentanyl, ASAM's 2023 expert consensus describes two newer approaches for when a standard start isn't possible: very small buprenorphine doses while the person keeps taking opioids, mostly used in hospitals, and a high-dose start once withdrawal has begun, mostly used in emergency departments.¹² If withdrawal follows a first dose, ASAM calls more buprenorphine, given by the clinician, the most effective treatment, with other medicines for symptoms; severe cases are managed in an emergency department.¹² If it happens to you, call the prescriber or clinic that started you, or go to an emergency room.

Starting naltrexone or Vivitrol. The labels call for at least 7 to 10 opioid-free days after short-acting opioids, and up to 2 weeks after buprenorphine or methadone.⁴ SAMHSA's guide gives 10 to 14 days after long-acting opioids.³ Clinicians may use a urine test and a naloxone challenge, a small naloxone dose to see whether withdrawal appears. Even so, the labels say "there is no completely reliable method" to confirm someone is opioid-free, and a few people have had withdrawal after passing both, usually after buprenorphine.⁴

In a trial of 150 adults, 56.1% got the shot after a 7-day outpatient schedule using small, rising naltrexone doses, against 32.7% after a buprenorphine taper and a week's wait.¹⁹ A trial of 378 found similar rates, 40.5% to 46.0%, across three schedules, one of them placebo.²⁰

How we checked

• Read on October 17, 2026: the Vivitrol, naltrexone tablet, Suboxone, Opvee, Zurnai, Narcan and naloxone injection labels; SAMHSA's TIP 63; the ASAM 2023 consensus; the D'Onofrio 2023 full text; Poison Control's site.
• Read as abstracts: the other studies. Gregory's 0% to 13.2% spans studies with different definitions.
• Case reports and the survey are labelled as such.^{1-6,8,9,12,14,16}

Getting help

• Emergency: call 911.
• Poison Control: 1-800-222-1222, free and confidential.⁸
• Crisis: call or text 988, the Suicide & Crisis Lifeline.²¹
• Treatment referrals: SAMHSA's National Helpline, 1-800-662-4357, free, confidential and open 24 hours a day.²²
• Find a program: FindTreatment.gov, run by SAMHSA, lists treatment facilities and the medicines they offer.²³